查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2127939

解剖學及病理學市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測

Anatomic Pathology Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 261 Pages | 商品交期: 2-3個工作天內

價格

解剖病理市場成長要素

全球解剖病理學市場預估2025年達到377.4億美元，2026年成長至402.9億美元，2034年達到740.4億美元，預測期內複合年成長率（CAGR）為7.90%。北美地區引領全球市場，預計到2025年將佔36.18%的市場佔有率，這得益於其先進的醫療基礎設施、龐大的診斷檢測量以及數位病理技術的快速普及。

解剖病理學是一門醫學專科，透過檢查組織、器官和細胞來診斷疾病。它在識別癌症、發炎性疾病和自體免疫疾病等慢性疾病方面發揮著至關重要的作用。慢性疾病發生率的上升、癌症篩檢計畫的擴展以及對個人化醫療日益成長的需求，正顯著推動組織病理學、免疫組織化學 (IHC)、分子病理學和數位病理學解決方案的應用。此外，研發投入的增加、技術的進步以及政府為加強診斷能力而採取的積極舉措，預計將在預測期內促進市場擴張。

慢性病負擔日益加重，推動市場擴張。

慢性病盛行率的不斷上升仍然是解剖病理學市場最強勁的成長要素之一。根據美國癌症協會預測，到2025年，美國預計將新增約200萬例癌症病例，將顯著增加對病理檢查和組織學診斷的需求。組織病理學和免疫組織化學仍然是癌症診斷的黃金標準，能夠幫助醫生做出準確的治療決策。

此外，發炎性腸道疾病、自體免疫疾病和感染疾病的發生率不斷上升，進一步推動了全球病理檢測需求的成長。各國政府和醫療機構正在擴大篩檢範圍，改善檢查室基礎設施，加速醫院和診斷檢查室對相關產品的應用。

正在改變診斷工作流程的技術進步

快速的技術創新是全球解剖病理學市場的一大趨勢。人工智慧（AI）、數位病理學、分子診斷、全切片成像和自動化組織處理系統的整合，在提高診斷準確性的同時，也縮短了檢測結果的報告時間。

數位病理平台支援遠距會診、人工智慧影像分析和高效的檢查室工作流程。領先企業正大力投資下一代病理解決方案，以提高生產力和診斷準確性。預計在預測期內，基於雲端的病理平台和人工智慧決策支援系統的日益普及將重塑病理檢查室的格局。

高昂的設備成本仍是市場成長面臨的一大挑戰。

儘管市場需求強勁，但先進病理設備的高成本仍是一大挑戰。數位病理掃描儀、自動化組織處理系統、分子診斷平台和人工智慧系統都需要大量的資金投入，這限制了它們在中小型檢查室的應用。

此外，開發中國家也面臨許多挑戰，例如熟練病理學家短缺、檢查室基礎設施落後、保險報銷問題以及阻礙技術普及的監管障礙。這些因素會阻礙市場滲透，尤其是在新興經濟體。

市場區隔

按產品類型分類，受對技術先進的病理診斷設備和耗材的需求不斷成長的推動，預計到 2026 年，該產品細分市場將佔全球市場佔有率的 63.13%，主導市場。

按應用領域分類，受癌症發病率上升和診斷檢測增加的推動，預計到 2026 年，疾病診斷領域將佔市場佔有率的 71.64%。

按技術分類，組織病理學預計到 2026 年將以 45.62% 的市場佔有率引領市場，因為它在癌症和慢性疾病的診斷中得到了廣泛應用。

按最終用戶分類，醫院和門診手術中心 (ASC) 預計將成為市場的主要驅動力，到 2026 年將佔 56.54% 的市場佔有率，這主要得益於全球患者數量的增加、手術數量的增加以及醫院基礎設施的擴張。

區域分析

預計北美市場規模將在2025年達到136.5億美元，繼續保持其領先區域市場的地位，並預計在2026年達到146.3億美元。該地區受益於先進的醫療基礎設施、數位病理學的廣泛應用、健全的保險報銷體係以及持續的產品創新。光是美國市場預計在2026年就將達到126.9億美元。

在歐洲，受數位病理系統普及率提高、政府支持以及癌症篩檢計畫擴展的推動，市場持續穩定成長。預計到2026年，該地區市場規模將達到99.8億美元。

亞太地區到 2025 年將達到 110.7 億美元，預計到 2026 年將成長到 117.8 億美元，這主要得益於中國、印度和日本慢性病患病率的上升、醫療基礎設施的改善以及診斷服務覆蓋範圍的擴大。

預計拉丁美洲市場規模將在2025年達到23.8億美元，2026年達到25.3億美元。同時，在醫療保健現代化努力和早期疾病診斷意識提高的推動下，中東和非洲市場預計將從2025年的13億美元成長到2026年的13.8億美元。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 2025/2026年主要國家和地區主要疾病的流行情況
  • 新產品發布，主要公司
  • 產業重大發展：合併、收購與合作。

第5章：2021-2034年全球解剖學與病理學市場分析、洞察與預測

  • 市場分析、洞察與預測：按類型
    • 服務
  • 市場分析、洞察與預測：按應用領域分類
    • 疾病診斷
    • 藥物發現
    • 其他
  • 市場分析、洞察與預測：按方法論分類
    • 組織病理學
    • 免疫組織化學（IHC）
    • 原位雜合反應
    • 分子病理學
    • 其他
  • 市場分析、洞察與預測：按最終用戶分類
    • 醫院/門診手術中心
    • 專科診所
    • 臨床實驗室
    • 其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美解剖學和病理學市場分析、洞察和預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲解剖學和病理學市場分析、洞察和預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區解剖病理學市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 澳洲
    • 中國
    • 印度
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲解剖學和病理學市場分析、洞察和預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲解剖病理學市場分析、洞察與預測（2021-2034年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • Cardinal Health
    • F. Hoffmann La. Roche Ltd.
    • Avantor, Inc.
    • Danaher Corporation
    • SLMP, LLC.
    • Agilent Technologies, Inc.
    • Indica Labs, LLC.
    • Hologic, Inc.
Product Code: FBI114388

Growth Factors of anatomic pathology Market

The global anatomic pathology market was valued at USD 37.74 billion in 2025 and is projected to grow from USD 40.29 billion in 2026 to USD 74.04 billion by 2034, registering a CAGR of 7.90% during the forecast period. North America dominated the global market with a 36.18% market share in 2025, supported by advanced healthcare infrastructure, high diagnostic test volumes, and rapid adoption of digital pathology technologies.

Anatomic pathology is a specialized branch of medicine that diagnoses diseases by examining tissues, organs, and cells. It plays a critical role in identifying chronic diseases such as cancer, inflammatory disorders, and autoimmune conditions. Rising incidences of chronic illnesses, increasing cancer screening programs, and growing demand for personalized medicine are significantly driving the adoption of histopathology, immunohistochemistry (IHC), molecular pathology, and digital pathology solutions. Moreover, increasing investments in research and development, technological advancements, and favorable government initiatives aimed at strengthening diagnostic capabilities are expected to fuel market expansion throughout the forecast period.

Growing Burden of Chronic Diseases Driving Market Expansion

The increasing prevalence of chronic diseases remains one of the strongest growth drivers for the anatomic pathology market. According to the American Cancer Society, nearly 2 million new cancer cases are expected to be diagnosed in the U.S. during 2025, creating substantial demand for pathology testing and tissue-based diagnostics. Histopathology and immunohistochemistry continue to serve as the gold standard for cancer diagnosis, enabling physicians to make accurate treatment decisions.

Additionally, the growing incidence of inflammatory bowel disease, autoimmune disorders, and infectious diseases is further increasing pathology test volumes worldwide. Governments and healthcare organizations are expanding screening initiatives and improving laboratory infrastructure, accelerating product adoption across hospitals and diagnostic laboratories.

Technological Advancements Transforming Diagnostic Workflows

Rapid technological innovation has become a defining trend in the global anatomic pathology market. The integration of artificial intelligence (AI), digital pathology, molecular diagnostics, whole-slide imaging, and automated tissue processing systems is improving diagnostic accuracy while reducing turnaround times.

Digital pathology platforms allow remote consultations, AI-assisted image analysis, and efficient laboratory workflows. Major companies are investing heavily in next-generation pathology solutions to improve productivity and diagnostic precision. Increasing adoption of cloud-based pathology platforms and AI-enabled decision support systems is expected to reshape pathology laboratories during the forecast period.

High Equipment Costs Continue to Challenge Market Growth

Despite strong market demand, the high cost of advanced pathology instruments remains a significant challenge. Digital pathology scanners, automated tissue processors, molecular diagnostic platforms, and AI-enabled systems require substantial capital investment, limiting adoption among small and mid-sized laboratories.

Developing countries also face shortages of skilled pathologists, limited laboratory infrastructure, reimbursement challenges, and regulatory barriers that delay technology adoption. These factors may restrict market penetration, particularly across emerging economies.

Market Segmentation

Based on type, the products segment is expected to dominate the global market with a 63.13% share in 2026, driven by increasing demand for technologically advanced pathology instruments and consumables.

By application, the disease diagnosis segment will account for 71.64% of the market in 2026, supported by rising cancer incidence and increasing diagnostic testing.

Based on technique, histopathology is projected to lead the market with a 45.62% share in 2026, owing to its extensive use in diagnosing cancer and chronic diseases.

By end-user, hospitals & ambulatory surgery centers (ASCs) are expected to dominate with a 56.54% market share in 2026, supported by growing patient admissions, increasing surgical procedures, and expanding hospital infrastructure worldwide.

Regional Analysis

North America remained the leading regional market with a value of USD 13.65 billion in 2025 and is projected to reach USD 14.63 billion in 2026. The region benefits from advanced healthcare infrastructure, widespread adoption of digital pathology, strong reimbursement systems, and continuous product innovations. The U.S. market alone is estimated to reach USD 12.69 billion in 2026.

Europe continues to witness steady growth due to increasing adoption of digital pathology systems, favorable government initiatives, and expanding cancer screening programs. The regional market is projected to reach USD 9.98 billion in 2026.

Asia Pacific accounted for USD 11.07 billion in 2025 and is projected to grow to USD 11.78 billion in 2026, driven by rising chronic disease prevalence, improving healthcare infrastructure, and expanding access to diagnostic services across China, India, and Japan.

Latin America generated USD 2.38 billion in 2025 and is expected to reach USD 2.53 billion in 2026, while the Middle East & Africa market is projected to grow from USD 1.30 billion in 2025 to USD 1.38 billion in 2026, supported by healthcare modernization initiatives and increasing awareness regarding early disease diagnosis.

Competitive Landscape

The global anatomic pathology market remains highly competitive, with leading companies continuously investing in product innovation, acquisitions, and regulatory approvals to strengthen their market positions. Major industry participants include Cardinal Health, F. Hoffmann-La Roche Ltd., Avantor Inc., Danaher Corporation, SLMP, LLC., Agilent Technologies, Inc., Indica Labs, LLC., and Hologic, Inc.

Recent industry developments highlight the rapid pace of innovation. In September 2025, Labcorp partnered with F. Hoffmann-La Roche Ltd. to implement Roche's FDA-cleared digital pathology slide scanners. In July 2025, PathAI introduced its Precision Pathology Network to strengthen digital pathology workflows, while Techcyte launched its Fusion SaaS platform to integrate anatomic and clinical pathology operations. Earlier, StatLab Medical Products expanded its global footprint through the acquisition of Diapath S.p.A., strengthening its histology product portfolio.

Conclusion

The global anatomic pathology market is poised for sustained growth over the forecast period, driven by rising prevalence of chronic diseases, increasing cancer diagnosis rates, expanding digital pathology adoption, and continuous technological advancements. Growing investments in AI-enabled diagnostics, precision medicine, and laboratory automation are expected to further transform pathology workflows worldwide. Although high equipment costs and limited access to skilled professionals remain key challenges in developing regions, expanding healthcare infrastructure, supportive government initiatives, and continuous product innovation are expected to create significant growth opportunities, positioning the market for strong long-term expansion through 2034.

Segmentation By Type

  • Products
    • Instruments
  • Microtomes
  • Tissue Processing Systems
  • Stainers
  • Others
    • Consumables
  • Services

By Application

  • Disease Diagnosis
  • Drug Discovery
  • Others

By Technique

  • Histopathology
  • Immunohistochemistry (IHC)
  • In-situ Hybridization
  • Molecular Pathology
  • Others

By End User

  • Hospitals & ASCs
  • Specialty Clinics
  • Clinical Laboratories
  • Others

By Region

  • North America (By Type, By Application, By Technique, By End User, and by Country)
    • U.S. (By Application)
    • Canada (By Application)
  • Europe (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
    • U.K. (By Application)
    • Germany (By Application)
    • France (By Application)
    • Italy (By Application)
    • Spain (By Application)
    • Scandinavia (By Application)
    • Rest of Europe (By Application)
  • Asia Pacific (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
    • China (By Application)
    • Japan (By Application)
    • India (By Application)
    • Australia (By Application)
    • Southeast Asia (By Application)
    • Rest of Asia Pacific (By Application)
  • Latin America (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
    • Brazil (By Application)
    • Mexico (By Application)
    • Rest of Latin America (By Application)
  • Middle East & Africa (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
    • GCC (By Application)
    • South Africa (By Application)
    • Rest of the Middle East & Africa (By Application)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2025/2026
  • 4.2. New Product Launches, Key Players
  • 4.3. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Products
      • 5.1.1.1. Instruments
        • 5.1.1.1.1. Microtomes
        • 5.1.1.1.2. Tissue Processing Systems
        • 5.1.1.1.3. Stainers
        • 5.1.1.1.4. Others
      • 5.1.1.2. Consumables
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Disease Diagnosis
    • 5.2.2. Drug Discovery
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Technique
    • 5.3.1. Histopathology
    • 5.3.2. Immunohistochemistry (IHC)
    • 5.3.3. In-situ Hybridization
    • 5.3.4. Molecular Pathology
    • 5.3.5. Others
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Hospitals & ASCs
    • 5.4.2. Specialty Clinics
    • 5.4.3. Clinical Laboratories
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Products
      • 6.1.1.1. Instruments
        • 6.1.1.1.1. Microtomes
        • 6.1.1.1.2. Tissue Processing Systems
        • 6.1.1.1.3. Stainers
        • 6.1.1.1.4. Others
      • 6.1.1.2. Consumables
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Disease Diagnosis
    • 6.2.2. Drug Discovery
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Technique
    • 6.3.1. Histopathology
    • 6.3.2. Immunohistochemistry (IHC)
    • 6.3.3. In-situ Hybridization
    • 6.3.4. Molecular Pathology
    • 6.3.5. Others
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Hospitals & ASCs
    • 6.4.2. Specialty Clinics
    • 6.4.3. Clinical Laboratories
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
      • 6.5.1.1. By Application
    • 6.5.2. Canada
      • 6.5.2.1. By Application

7. Europe Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Products
      • 7.1.1.1. Instruments
        • 7.1.1.1.1. Microtomes
        • 7.1.1.1.2. Tissue Processing Systems
        • 7.1.1.1.3. Stainers
        • 7.1.1.1.4. Others
      • 7.1.1.2. Consumables
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Disease Diagnosis
    • 7.2.2. Drug Discovery
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Technique
    • 7.3.1. Histopathology
    • 7.3.2. Immunohistochemistry (IHC)
    • 7.3.3. In-situ Hybridization
    • 7.3.4. Molecular Pathology
    • 7.3.5. Others
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Hospitals & ASCs
    • 7.4.2. Specialty Clinics
    • 7.4.3. Clinical Laboratories
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
      • 7.5.1.1. By Application
    • 7.5.2. Germany
      • 7.5.2.1. By Application
    • 7.5.3. France
      • 7.5.3.1. By Application
    • 7.5.4. Spain
      • 7.5.4.1. By Application
    • 7.5.5. Italy
      • 7.5.5.1. By Application
    • 7.5.6. Scandinavia
      • 7.5.6.1. By Application
    • 7.5.7. Rest of Europe
      • 7.5.7.1. By Application

8. Asia Pacific Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Products
      • 8.1.1.1. Instruments
        • 8.1.1.1.1. Microtomes
        • 8.1.1.1.2. Tissue Processing Systems
        • 8.1.1.1.3. Stainers
        • 8.1.1.1.4. Others
      • 8.1.1.2. Consumables
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Disease Diagnosis
    • 8.2.2. Drug Discovery
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Technique
    • 8.3.1. Histopathology
    • 8.3.2. Immunohistochemistry (IHC)
    • 8.3.3. In-situ Hybridization
    • 8.3.4. Molecular Pathology
    • 8.3.5. Others
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Hospitals & ASCs
    • 8.4.2. Specialty Clinics
    • 8.4.3. Clinical Laboratories
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
      • 8.5.1.1. By Application
    • 8.5.2. Australia
      • 8.5.2.1. By Application
    • 8.5.3. China
      • 8.5.3.1. By Application
    • 8.5.4. India
      • 8.5.4.1. By Application
    • 8.5.5. Southeast Asia
      • 8.5.5.1. By Application
    • 8.5.6. Rest of Asia Pacific
      • 8.5.6.1. By Application

9. Latin America Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Products
      • 9.1.1.1. Instruments
        • 9.1.1.1.1. Microtomes
        • 9.1.1.1.2. Tissue Processing Systems
        • 9.1.1.1.3. Stainers
        • 9.1.1.1.4. Others
      • 9.1.1.2. Consumables
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Disease Diagnosis
    • 9.2.2. Drug Discovery
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Technique
    • 9.3.1. Histopathology
    • 9.3.2. Immunohistochemistry (IHC)
    • 9.3.3. In-situ Hybridization
    • 9.3.4. Molecular Pathology
    • 9.3.5. Others
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Hospitals & ASCs
    • 9.4.2. Specialty Clinics
    • 9.4.3. Clinical Laboratories
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
      • 9.5.1.1. By Application
    • 9.5.2. Mexico
      • 9.5.2.1. By Application
    • 9.5.3. Rest of Latin America
      • 9.5.3.1. By Application

10. Middle East & Africa Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Products
      • 10.1.1.1. Instruments
        • 10.1.1.1.1. Microtomes
        • 10.1.1.1.2. Tissue Processing Systems
        • 10.1.1.1.3. Stainers
        • 10.1.1.1.4. Others
      • 10.1.1.2. Consumables
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Disease Diagnosis
    • 10.2.2. Drug Discovery
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Technique
    • 10.3.1. Histopathology
    • 10.3.2. Immunohistochemistry (IHC)
    • 10.3.3. In-situ Hybridization
    • 10.3.4. Molecular Pathology
    • 10.3.5. Others
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Hospitals & ASCs
    • 10.4.2. Specialty Clinics
    • 10.4.3. Clinical Laboratories
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
      • 10.5.1.1. By Application
    • 10.5.2. South Africa
      • 10.5.2.1. By Application
    • 10.5.3. Rest of Middle East & Africa
      • 10.5.3.1. By Application

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Cardinal Health
    • 11.2.2. F. Hoffmann La. Roche Ltd.
    • 11.2.3. Avantor, Inc.
    • 11.2.4. Danaher Corporation
    • 11.2.5. SLMP, LLC.
    • 11.2.6. Agilent Technologies, Inc.
    • 11.2.7. Indica Labs, LLC.
    • 11.2.8. Hologic, Inc.

List of Tables

  • Table 1: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 3: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by Instruments, 2021-2034
  • Table 4: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 5: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 6: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 7: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 8: North America Anatomic Pathology Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 9: North America Anatomic Pathology Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 10: North America Anatomic Pathology Market Revenue (USD billion) Forecast, by Instruments, 2021-2034
  • Table 11: North America Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 12: North America Anatomic Pathology Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 13: North America Anatomic Pathology Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 14: North America Anatomic Pathology Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 15: U.S. Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 16: Canada Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 17: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 18: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 19: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by Instruments, 2021-2034
  • Table 20: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 21: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 22: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 23: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 24: Germany Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 25: U.K. Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 26: France Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 27: Italy Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 28: Spain Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 29: Scandinavia Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 30: Rest of Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 31: Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 32: Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 33: Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, by Instruments, 2021-2034
  • Table 34: Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 35: Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 36: Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 37: China Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 38: Japan Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 39: India Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 40: Australia Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 41: Southeast Asia Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 42: Rest of Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 43: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 44: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 45: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by Instruments, 2021-2034
  • Table 46: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 47: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 48: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 49: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 50: Brazil Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 51: Mexico Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 52: Rest of Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 53: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 54: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 55: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Instruments, 2021-2034
  • Table 56: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 57: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 58: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 59: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 60: GCC Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 61: South Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 62: Rest of Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034

List of Figures

  • Figure 1: Global Anatomic Pathology Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Anatomic Pathology Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Anatomic Pathology Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Anatomic Pathology Market Value Share (%), by Technique, 2025 & 2034
  • Figure 5: Global Anatomic Pathology Market Value Share (%), by End User, 2025 & 2034
  • Figure 6: Global Anatomic Pathology Market Value Share (%), by Region, 2025 & 2034
  • Figure 7: North America Anatomic Pathology Market Value (USD billion), by Type, 2025 & 2034
  • Figure 8: North America Anatomic Pathology Market Value Share (%), by Type, 2025
  • Figure 9: North America Anatomic Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 10: North America Anatomic Pathology Market Value Share (%), by Application, 2025
  • Figure 11: North America Anatomic Pathology Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 12: North America Anatomic Pathology Market Value Share (%), by Technique, 2025
  • Figure 13: North America Anatomic Pathology Market Value (USD billion), by End User, 2025 & 2034
  • Figure 14: North America Anatomic Pathology Market Value Share (%), by End User, 2025
  • Figure 15: North America Anatomic Pathology Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Anatomic Pathology Market Value Share (%), By Country, 2025
  • Figure 17: Europe Anatomic Pathology Market Value (USD billion), by Type, 2025 & 2034
  • Figure 18: Europe Anatomic Pathology Market Value Share (%), by Type, 2025
  • Figure 19: Europe Anatomic Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 20: Europe Anatomic Pathology Market Value Share (%), by Application, 2025
  • Figure 21: Europe Anatomic Pathology Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 22: Europe Anatomic Pathology Market Value Share (%), by Technique, 2025
  • Figure 23: Europe Anatomic Pathology Market Value (USD billion), by End User, 2025 & 2034
  • Figure 24: Europe Anatomic Pathology Market Value Share (%), by End User, 2025
  • Figure 25: Europe Anatomic Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Anatomic Pathology Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Anatomic Pathology Market Value (USD billion), by Type, 2025 & 2034
  • Figure 28: Asia Pacific Anatomic Pathology Market Value Share (%), by Type, 2025
  • Figure 29: Asia Pacific Anatomic Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 30: Asia Pacific Anatomic Pathology Market Value Share (%), by Application, 2025
  • Figure 31: Asia Pacific Anatomic Pathology Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 32: Asia Pacific Anatomic Pathology Market Value Share (%), by Technique, 2025
  • Figure 33: Asia Pacific Anatomic Pathology Market Value (USD billion), by End User, 2025 & 2034
  • Figure 34: Asia Pacific Anatomic Pathology Market Value Share (%), by End User, 2025
  • Figure 35: Asia Pacific Anatomic Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Anatomic Pathology Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Anatomic Pathology Market Value (USD billion), by Type, 2025 & 2034
  • Figure 38: Latin America Anatomic Pathology Market Value Share (%), by Type, 2025
  • Figure 39: Latin America Anatomic Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 40: Latin America Anatomic Pathology Market Value Share (%), by Application, 2025
  • Figure 41: Latin America Anatomic Pathology Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 42: Latin America Anatomic Pathology Market Value Share (%), by Technique, 2025
  • Figure 43: Latin America Anatomic Pathology Market Value (USD billion), by End User, 2025 & 2034
  • Figure 44: Latin America Anatomic Pathology Market Value Share (%), by End User, 2025
  • Figure 45: Latin America Anatomic Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Anatomic Pathology Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Anatomic Pathology Market Value (USD billion), by Type, 2025 & 2034
  • Figure 48: Middle East & Africa Anatomic Pathology Market Value Share (%), by Type, 2025
  • Figure 49: Middle East & Africa Anatomic Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 50: Middle East & Africa Anatomic Pathology Market Value Share (%), by Application, 2025
  • Figure 51: Middle East & Africa Anatomic Pathology Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 52: Middle East & Africa Anatomic Pathology Market Value Share (%), by Technique, 2025
  • Figure 53: Middle East & Africa Anatomic Pathology Market Value (USD billion), by End User, 2025 & 2034
  • Figure 54: Middle East & Africa Anatomic Pathology Market Value Share (%), by End User, 2025
  • Figure 55: Middle East & Africa Anatomic Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Anatomic Pathology Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Anatomic Pathology Market Share (%), By Company, 2025